Exhibit 99.1 Cytek Biosciences Reports Second Quarter 2025 Financial Results FREMONT, Calif., August 6, 2025 (GLOBE NEWSWIRE) – Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2025. Second Quarter Highlights "The progress we achieved in the first half of this year is underscored by steady growth in our FSP unit placements, and in our recurring revenue businesses, despit ...